ORION Corp. (KRX:271560)
South Korea
· Delayed Price · Currency is KRW | Market Cap | 4.21T |
| Revenue (ttm) | 3.16T |
| Net Income (ttm) | 535.08B |
| Shares Out | 39.53M |
| EPS (ttm) | 13,536.00 |
| PE Ratio | 7.88 |
| Forward PE | 9.34 |
| Dividend | 2,500.00 (2.32%) |
| Ex-Dividend Date | Feb 27, 2025 |
| Volume | 112,159 |
| Average Volume | 160,251 |
| Open | 108,400 |
| Previous Close | 108,600 |
| Day's Range | 106,500 - 108,500 |
| 52-Week Range | 81,800 - 127,300 |
| Beta | 0.27 |
| RSI | 34.70 |
| Earnings Date | Aug 14, 2025 |
About ORION
ORION Corp., together with its subsidiaries, engages in the manufacture and sale of various confectionery products in South Korea, China, and internationally. It offers pies, snacks, biscuits, candies, gums, and chocolates; protein drinks/powders, bars/balls bars, and drinks; and granola and granola bars products; and mineral water under the Orion Power, Dr.You, Market O, Market O Nature, and Jeju yongamsoo brands. The company also produces and distributes films; and provides in vitro diagnostics for early detection of cancer, and vaccines for ... [Read more]
Financial Performance
In 2024, ORION's revenue was 3.10 trillion, an increase of 6.59% compared to the previous year's 2.91 trillion. Earnings were 524.59 billion, an increase of 39.28%.
Financial StatementsNews
Shilpa Medicare subsidiary partners with Orion Corporation to commercialize Recombinant Human Albumin in Europe
Shilpa Medicare Limited has announced that its wholly owned subsidiary, Shilpa Biocare Private Limited, has entered into a strategic agreement with Orion Corporation, a pharmaceutical company based in...